SCHEMBL7608445

SCHEMBL7608445

Cn1c(=O)n(COc2ccc(Cl)cc2)c(=O)c2[nH]cnc21

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE4A P27815 9/20 0.60
▸ PDE4B Q07343 9/20 0.60
▸ PDE4C Q08493 9/20 0.60
▸ PDE4D Q08499 9/20 0.60
▸ ADORA2B P29275 8/20 0.60
▸ ADORA2A P29274 8/20 0.60
▸ ADORA3 P0DMS8 5/20 0.59
▸ CFTR P13569 2/20 0.56
▸ NPC1 O15118 1/20 0.55
▸ ATAD2 Q6PL18 1/20 0.52
▸ ADORA1 P30542 2/20 0.51
▸ PIK3CD O00329 1/20 0.51
▸ ALPL P05186 1/20 0.51
▸ TMIGD3 P0DMS9 1/20 0.51
▸ CYP2C19 P33261 1/20 0.51
▸ HIF1A Q16665 1/20 0.51
▸ CYP1A2 P05177 2/20 0.50
▸ LMNA P02545 1/20 0.50
▸ MAPT P10636 1/20 0.50
▸ CHIT1 Q13231 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7608745 0.80 ADORA2B (0.71) PDE4APDE4BPDE4CPDE4DADORA2B
SCHEMBL7606755 0.79 ADORA2B (0.58) PDE4APDE4BPDE4CPDE4DADORA2B
SCHEMBL7455363 0.78 ADORA2A (0.72) PDE4APDE4BPDE4CPDE4DADORA2B
SCHEMBL28324505 0.78 ADORA2B (0.73) PDE4APDE4BPDE4CPDE4DADORA2B
SCHEMBL27598085 0.77 PDE4A (0.75) PDE4APDE4BPDE4CPDE4DADORA2B
SCHEMBL8648443 0.77 ADORA2B (0.67) PDE4APDE4BPDE4CPDE4DADORA2B
SCHEMBL7603135 0.77 ADORA2B (0.70) PDE4APDE4BPDE4CPDE4DADORA2B
SCHEMBL7016029 0.76 ADORA2A (1.00) PDE4APDE4BPDE4CPDE4DADORA2B
SCHEMBL7607714 0.75 CFTR (0.70) PDE4APDE4BPDE4CPDE4DADORA2B
SCHEMBL7605748 0.75 ADORA2B (0.63) PDE4APDE4BPDE4CPDE4DADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0812844-B1 Use of theophyllin derivatives for the treatment and prophylaxis fo shock conditions, novel xanthine compounds and processes for the production thereof HOECHST AG (DE) 2002-10-23 — — EP disclosed
CN-1066146-C Use of theophylline derivatives for curing and preventing shock state, xanthine derivatives and preparation thereof AVENTIS PHARMACEUTICALS AG (DE) 2001-05-23 — — CN disclosed
US-6214992-B1 THEOPHYLLINE DERIVATIVES HAVING AT LEAST ONE ETHER FUNCTION IN METHYL RADICAL; XANTHINE COMPOUNDS WITH THIS SUBSTITUTION PATTERN USED AS ANTISHOCK TREATMENT HOECHST AKTIENGESELLSCHAFT (DE) 2001-04-10 — — US disclosed
CN-1169993-A Use of theophylline derivatives for curing and preventing shock state, xanthine derivatives and preparation thereof HOECHST AG (DE) 1998-01-14 — — CN disclosed
EP-0812844-A2 Use of theophyllin derivatives for the treatment and prophylaxis fo shock conditions, novel xanthine compounds and processes for the production thereof HOECHST AKTIENGESELLSCHAFT (DE) 1997-12-17 — — EP disclosed
Send feedback